ClinicalTrials.Veeva

Menu

The Roles of IL-9/E-cadherin and Ferroptosis in Intestinal Mucosal Barrier Injury in Sepsis

N

Nanjing Medical University

Status

Enrolling

Conditions

Intestinal Mucosal Barrier
Ferroptosis
Sepsis

Treatments

Procedure: Standard treatments for sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT05410665
YKK21134

Details and patient eligibility

About

The investigators aim to evaluate the roles of IL-9/E-cadheirin and ferroptosis in the intestinal mucosal barrier injury of sepsis. The results of this study would lay the foundation for revealing the mechanisms of EEN improving immune imbalance of sepsis and provide a new idea to the early treatment of sepsis.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Clinical diagnosis of sepsis
  2. Within 3 days of sepsis onset before ICU admission
  3. No artificial nutrition (enteral or parenteral nutrition) were provided before ICU admission

Exclusion criteria

  1. Ileus
  2. Digestive tract hemorrhage
  3. Inflammatory bowel disease
  4. Cancer or chronic organ dysfunction (e.g., hepatic or renal dysfunction)
  5. Malnutrition or immunodeficiency
  6. Long-term use of hormones

Trial design

100 participants in 2 patient groups

Sepsis group
Description:
Adult septic patients admitted into the intensive care unit (ICU) of Nanjing First Hospital. The diagnostic criteria for sepsis were in accordance with the surviving sepsis guidelines.
Treatment:
Procedure: Standard treatments for sepsis
Control group
Description:
Baseline data (including age, sex, body-mass index, disease severity scores) matched adult non-septic critical patients in our ICU.

Trial contacts and locations

1

Loading...

Central trial contact

Jie Zhou, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems